BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9335039)

  • 21. Retinitis pigmentosa associated with rhodopsin mutations: Correlation between phenotypic variability and molecular effects.
    Iannaccone A; Man D; Waseem N; Jennings BJ; Ganapathiraju M; Gallaher K; Reese E; Bhattacharya SS; Klein-Seetharaman J
    Vision Res; 2006 Dec; 46(27):4556-67. PubMed ID: 17014888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A transgenic mouse model for gene therapy of rhodopsin-linked Retinitis Pigmentosa.
    O'Reilly M; Millington-Ward S; Palfi A; Chadderton N; Cronin T; McNally N; Humphries MM; Humphries P; Kenna PF; Farrar GJ
    Vision Res; 2008 Feb; 48(3):386-91. PubMed ID: 17920651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy and retinitis pigmentosa: advances and future challenges.
    Dejneka NS; Bennett J
    Bioessays; 2001 Jul; 23(7):662-8. PubMed ID: 11462220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A diffusible factor from normal retinal cells promotes rod photoreceptor survival in an in vitro model of retinitis pigmentosa.
    Streichert LC; Birnbach CD; Reh TA
    J Neurobiol; 1999 Jun; 39(4):475-90. PubMed ID: 10380070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations.
    Berson EL; Rosner B; Weigel-DiFranco C; Dryja TP; Sandberg MA
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3027-36. PubMed ID: 12202526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinopathy mutations in the bZIP protein NRL alter phosphorylation and transcriptional activity.
    Kanda A; Friedman JS; Nishiguchi KM; Swaroop A
    Hum Mutat; 2007 Jun; 28(6):589-98. PubMed ID: 17335001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Retinitis pigmentosa and its experimental model: II. Electrophysiological investigations (author's transl)].
    Sole P; Alfieri R; Kapuściński C; Bacin F; Bussière M; Kantelip B
    Klin Oczna; 1981 Nov; 82(11):561-2. PubMed ID: 7218719
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical features and mutations in patients with dominant retinitis pigmentosa-1 (RP1).
    Berson EL; Grimsby JL; Adams SM; McGee TL; Sweklo E; Pierce EA; Sandberg MA; Dryja TP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2217-24. PubMed ID: 11527933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of cone molecular markers in rhodopsin-mutant human retinas with retinitis pigmentosa.
    John SK; Smith JE; Aguirre GD; Milam AH
    Mol Vis; 2000 Nov; 6():204-15. PubMed ID: 11063754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease expression of RP1 mutations causing autosomal dominant retinitis pigmentosa.
    Jacobson SG; Cideciyan AV; Iannaccone A; Weleber RG; Fishman GA; Maguire AM; Affatigato LM; Bennett J; Pierce EA; Danciger M; Farber DB; Stone EM
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1898-908. PubMed ID: 10845615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A Chinese family with autosomal dominant retinitis pigmentosa and a pro347Leu rhodopsin gene mutation].
    Yang H; Luo C; Zhou J; Yan M
    Chin Med J (Engl); 2000 Jun; 113(6):574-6. PubMed ID: 11775885
    [No Abstract]   [Full Text] [Related]  

  • 32. A mutation in NRL is associated with autosomal dominant retinitis pigmentosa.
    Bessant DA; Payne AM; Mitton KP; Wang QL; Swain PK; Plant C; Bird AC; Zack DJ; Swaroop A; Bhattacharya SS
    Nat Genet; 1999 Apr; 21(4):355-6. PubMed ID: 10192380
    [No Abstract]   [Full Text] [Related]  

  • 33. [Genetic analysis of rhodopsin and peripherin genes in patients with autosomal dominant retinitis pigmentosa (adRP) in Polish families].
    Brzeziańska E; Zdzieszyńska M; Goś R; Lewiński A
    Klin Oczna; 2004; 106(6):743-8. PubMed ID: 15787173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinal histopathology of an XLRP carrier with a mutation in the RPGR exon ORF15.
    Aguirre GD; Yashar BM; John SK; Smith JE; Breuer DK; Hiriyanna S; Swaroop A; Milam AH
    Exp Eye Res; 2002 Oct; 75(4):431-43. PubMed ID: 12387791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant retinal tight junction and adherens junction protein expression in an animal model of autosomal dominant Retinitis pigmentosa: the Rho(-/-) mouse.
    Campbell M; Humphries M; Kennan A; Kenna P; Humphries P; Brankin B
    Exp Eye Res; 2006 Sep; 83(3):484-92. PubMed ID: 16643895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic approach to the study of the nervous system.
    Pak WL; Pinto LH
    Annu Rev Biophys Bioeng; 1976; 5():397-448. PubMed ID: 782342
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical investigation of retinitis pigmentosa.
    Bird AC
    Prog Clin Biol Res; 1987; 247():3-20. PubMed ID: 3317446
    [No Abstract]   [Full Text] [Related]  

  • 38. Photoreceptor apoptosis in animal models. Implications for retinitis pigmentosa research.
    Wong F
    Arch Ophthalmol; 1995 Oct; 113(10):1245-7. PubMed ID: 7575254
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of retinitis pigmentosa--summary.
    Bird AC
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 4)():494-5. PubMed ID: 6589868
    [No Abstract]   [Full Text] [Related]  

  • 40. New tool for retinal degeneration research.
    Klassen H
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):926. PubMed ID: 22345364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.